A PHASE I SAFETY AND IMMUNOGENICITY TRIAL OF THE FACILITATED HIV-1 GAG-POL DNA VACCINE (APL-400-047, APOLLON, INC.) GIVEN INTRAMUSCULARLY BY NEEDLE AND SYRINGE OR BIOJECTOR 2000 NEEDLE-FREE JET INJECTION SYSTEM IN HIV-1 UNINFECTED ADULT VOLUNTEERS: